Advances in Hematological Malignancies
Recent centuries have witnessed remarkable progress in the domain of hematological malignancies. Novel treatment modalities such as targeted therapy, immunotherapies, and therapy are altering the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering potential for more curative treatment